78 results
Page 3 of 4
424B5
vkdhfs9uyk61m0a
8 Dec 20
Prospectus supplement for primary offering
5:30pm
424B5
ar93dwon6zv
7 Dec 20
Prospectus supplement for primary offering
5:20pm
S-3ASR
wwprcr
7 Dec 20
Automatic shelf registration
4:15pm
8-K
EX-99.1
buw ujcm5
9 Nov 20
Arcturus Therapeutics Announces Third Quarter 2020 Financial Results and Positive Clinical Updates for ARCT-810 Phase I Study and Additional ARCT-021 Interim Data
4:06pm
8-K
EX-99.1
2iqrxmvn1dv1qrm
10 Aug 20
Arcturus Therapeutics Announces Second Quarter 2020 Financial Results and Provides a Corporate Update
4:22pm
424B5
4ao92 m4rx
30 Jul 20
Prospectus supplement for primary offering
6:01am
8-K
EX-99.1
tes1q5 c8
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
424B5
esve3e4f
28 Jul 20
Prospectus supplement for primary offering
4:17pm
8-K
EX-99.1
0hxi8
7 May 20
Arcturus Therapeutics Announces First Quarter 2020 Financial
4:08pm
424B5
ov503if qotrgxppg2d
17 Apr 20
Prospectus supplement for primary offering
4:02pm
424B5
43yq0qrohu11ucy0
15 Apr 20
Prospectus supplement for primary offering
4:14pm
424B5
z0sv i1stq
27 Mar 20
Prospectus supplement for primary offering
5:19pm
10-K
819av
16 Mar 20
Annual report
11:09am
8-K
EX-99.1
577q6uzw1bxqg4n8e2yu
11 Mar 20
Arcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results
4:05pm